{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:35:17Z","timestamp":1771472117409,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T00:00:00Z","timestamp":1392681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00392-014-0678-2","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T14:35:44Z","timestamp":1392647744000},"page":"665-673","source":"Crossref","is-referenced-by-count":26,"title":["Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF"],"prefix":"10.1007","volume":"103","author":[{"given":"Ulrich","family":"Tebbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Tsch\u00f6pe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jost Henner","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lokies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Turgonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke M.","family":"Strunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Lins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"678_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2009.06.061","volume":"145","author":"F Mehrhof","year":"2010","unstructured":"Mehrhof F, Loffler M, Gelbrich G, Ozcelik C, Posch M, Hense HW, Keil U, Scheffold T et al (2010) A network against failing hearts\u2014introducing the German \u201cCompetence Network Heart Failure\u201d. Int J Cardiol 145:135\u2013138","journal-title":"Int J Cardiol"},{"key":"678_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/eurjhf\/hfq181","volume":"13","author":"V Braun","year":"2011","unstructured":"Braun V, Heintze C, Rufer V, Welke J, Stein T, Mehrhof F, Dini L (2011) Innovative strategy for implementing chronic heart failure guidelines among family physicians in different healthcare settings in Berlin. Eur J Heart Fail 13:93\u201399","journal-title":"Eur J Heart Fail"},{"key":"678_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.zefq.2009.11.001","volume":"104","author":"L Dini","year":"2010","unstructured":"Dini L, Heintze C, Welke J, Stein T, Rufer V, Braun V (2010) Are there any differences in guideline adherence to pharmacotherapy of heart failure between individual GP practices and Medical Care Centres (MCCs)? Z Evid Fortbild Qual Gesundhwes 104:113\u2013119","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"678_CR4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/eurjhf\/hfn041","volume":"11","author":"M Baumhakel","year":"2009","unstructured":"Baumhakel M, Muller U, Bohm M (2009) Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 11:299\u2013303","journal-title":"Eur J Heart Fail"},{"key":"678_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/intqhc\/mzh038","volume":"16","author":"WN Kasje","year":"2004","unstructured":"Kasje WN, Denig P, De Graeff PA, Haaijer-Ruskamp FM (2004) Physicians\u2019 views on joint treatment guidelines for primary and secondary care. Int J Qual Health Care 16:229\u2013236","journal-title":"Int J Qual Health Care"},{"key":"678_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1388-9842(03)00050-3","volume":"5","author":"FH Rutten","year":"2003","unstructured":"Rutten FH, Grobbee DE, Hoes AW (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5:337\u2013344","journal-title":"Eur J Heart Fail"},{"key":"678_CR7","first-page":"77","volume":"46","author":"FS Mair","year":"1996","unstructured":"Mair FS, Crowley TS, Bundred PE (1996) Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 46:77\u201379","journal-title":"Br J Gen Pract"},{"key":"678_CR8","first-page":"559","volume":"50","author":"S Hood","year":"2000","unstructured":"Hood S, Taylor S, Roeves A, Crook AM, Tlusty P, Cohen J, Kaddoura S, Hemingway H (2000) Are there age and sex differences in the investigation and treatment of heart failure? A population-based study. Br J Gen Pract 50:559\u2013563","journal-title":"Br J Gen Pract"},{"key":"678_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00392-011-0388-y","volume":"101","author":"C Zugck","year":"2012","unstructured":"Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V et al (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol 101:263\u2013272","journal-title":"Clin Res Cardiol"},{"key":"678_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00392-011-0348-6","volume":"101","author":"J Franke","year":"2012","unstructured":"Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M et al (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1\u201310","journal-title":"Clin Res Cardiol"},{"key":"678_CR11","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787\u20131847","journal-title":"Eur Heart J"},{"key":"678_CR12","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2009) National guideline chronic heart failure\u2014Long version. http:\/\/www.versorgungsleitlinien.de\/themen\/herzinsuffizienz\/pdf\/nvl_hi_lang.pdf"},{"key":"678_CR13","unstructured":"DEGAM. Guideline No. 9: heart failure. http:\/\/leitlinien.degam.de\/uploads\/media\/Langfassung_Herzinsuffizienz_1_E002BIndex.pdf"},{"key":"678_CR14","unstructured":"Ehlers APF, G\u00f6tting S (2007) The accountability requirements of section\u00a013550 of the cardiocomplex EBM. http:\/\/www.bnk.de\/uploads\/media\/0703_262.pdf"},{"key":"678_CR15","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2013) Physician group EBM. http:\/\/www.kbv.de\/8170.html"},{"key":"678_CR16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00392-012-0531-4","volume":"102","author":"M Schowalter","year":"2013","unstructured":"Schowalter M, Gelbrich G, Stork S, Langguth JP, Morbach C, Ertl G, Faller H, Angermann CE (2013) Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression. Clin Res Cardiol 102:269\u2013278","journal-title":"Clin Res Cardiol"},{"key":"678_CR17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/165019701750300654","volume":"33","author":"M Quittan","year":"2001","unstructured":"Quittan M, Wiesinger GF, Crevenna R, Nuhr MJ, Posch M, Hulsmann M, Muller D, Pacher R et al (2001) Cross-cultural adaptation of the Minnesota living with heart failure questionnaire for German-speaking patients. J Rehabil Med 33:182\u2013186","journal-title":"J Rehabil Med"},{"key":"678_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1388-9842(03)00049-7","volume":"5","author":"FH Rutten","year":"2003","unstructured":"Rutten FH, Grobbee DE, Hoes AW (2003) Diagnosis and management of heart failure: a questionnaire among general practitioners and cardiologists. Eur J Heart Fail 5:345\u2013348","journal-title":"Eur J Heart Fail"},{"key":"678_CR19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bmj.321.7269.1113","volume":"321","author":"J Mason","year":"2000","unstructured":"Mason J, Young P, Freemantle N, Hobbs R (2000) Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction. BMJ 321:1113\u20131116","journal-title":"BMJ"},{"key":"678_CR20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/hrt.71.6.584","volume":"71","author":"KW Clarke","year":"1994","unstructured":"Clarke KW, Gray D, Hampton JR (1994) Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 71:584\u2013587","journal-title":"Br Heart J"},{"key":"678_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/eurheartj\/12.11.1245-a","volume":"12","author":"J Remes","year":"1991","unstructured":"Remes J, Miettinen H, Reunanen A, Pyorala K (1991) Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12:315\u2013321","journal-title":"Eur Heart J"},{"key":"678_CR22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(02)11601-1","volume":"360","author":"JG Cleland","year":"2002","unstructured":"Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A et al (2002) Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): an international survey. Lancet 360:1631\u20131639","journal-title":"Lancet"},{"key":"678_CR23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejheart.2005.01.007","volume":"7","author":"T Jaarsma","year":"2005","unstructured":"Jaarsma T, Haaijer-Ruskamp FM, Sturm H, Van Veldhuisen DJ (2005) Management of heart failure in The Netherlands. Eur J Heart Fail 7:371\u2013375","journal-title":"Eur J Heart Fail"},{"key":"678_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11\u201321","journal-title":"N Engl J Med"},{"key":"678_CR25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00392-012-0489-2","volume":"102","author":"J Franke","year":"2013","unstructured":"Franke J, Wolter JS, Meme L, Keppler J, Tschierschke R, Katus HA, Zugck C (2013) Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed? Clin Res Cardiol 102:23\u201331","journal-title":"Clin Res Cardiol"},{"key":"678_CR26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00392-012-0467-8","volume":"102","author":"M Bohm","year":"2013","unstructured":"Bohm M, Borer J, Ford I, Gonzalez-Juanatey JR, Komajda M, Lopez-Sendon J, Reil JC, Swedberg K et al (2013) Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clin Res Cardiol 102:11\u201322","journal-title":"Clin Res Cardiol"},{"key":"678_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00392-010-0207-x","volume":"100","author":"JC Reil","year":"2011","unstructured":"Reil JC, Custodis F, Swedberg K, Komajda M, Borer JS, Ford I, Tavazzi L, Laufs U et al (2011) Heart rate reduction in cardiovascular disease and therapy. Clin Res Cardiol 100:11\u201319","journal-title":"Clin Res Cardiol"},{"key":"678_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-5273(96)02904-X","volume":"59","author":"AR Houghton","year":"1997","unstructured":"Houghton AR, Cowley AJ (1997) Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners? Int J Cardiol 59:7\u201310","journal-title":"Int J Cardiol"},{"key":"678_CR29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ahj.2004.06.030","volume":"149","author":"A Ahmed","year":"2005","unstructured":"Ahmed A, Centor RM, Weaver MT, Perry GJ (2005) A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications. Am Heart J 149:737\u2013743","journal-title":"Am Heart J"},{"key":"678_CR30","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1046\/j.1532-5415.2002.50457.x","volume":"50","author":"A Ahmed","year":"2002","unstructured":"Ahmed A, Kiefe CI, Allman RM, Sims RV, DeLong JF (2002) Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. J Am Geriatr Soc 50:1659\u20131666","journal-title":"J Am Geriatr Soc"},{"key":"678_CR31","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/eurheartj\/ehi473","volume":"26","author":"A Jost","year":"2005","unstructured":"Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A et al (2005) Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study. Eur Heart J 26:2689\u20132697","journal-title":"Eur Heart J"},{"key":"678_CR32","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ehj.2004.05.022","volume":"25","author":"PC Deedwania","year":"2004","unstructured":"Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JC, Group M-HS (2004) Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR\/XL in elderly patients with heart failure. Eur Heart J 25:1300\u20131309","journal-title":"Eur Heart J"},{"key":"678_CR33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2753.2010.01455.x","volume":"16","author":"M Bosch","year":"2010","unstructured":"Bosch M, Wensing M, Bakx JC, van der Weijden T, Hoes AW, Grol RP (2010) Current treatment of chronic heart failure in primary care; still room for improvement. J Eval Clin Pract 16:644\u2013650","journal-title":"J Eval Clin Pract"},{"key":"678_CR34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00392-013-0558-1","volume":"102","author":"A Schuchert","year":"2013","unstructured":"Schuchert A, Muto C, Maounis T, Frank R, Ella RO, Polauck A, Padeletti L, Mascot Study G (2013) One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients. Clin Res Cardiol 102:505\u2013511","journal-title":"Clin Res Cardiol"},{"key":"678_CR35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321","journal-title":"N Engl J Med"},{"key":"678_CR36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"678_CR37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00059-011-3568-7","volume":"37","author":"DB Gysan","year":"2012","unstructured":"Gysan DB, Albus C, Riedel R, Hossmann V, Vogt A, Latz V, Griebenow R (2012) CorBene: a new model for collaborative care of patients with congestive heart failure. Herz 37:56\u201358","journal-title":"Herz"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-014-0678-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-014-0678-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-014-0678-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T08:57:06Z","timestamp":1716541026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-014-0678-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,18]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1007\/s00392-014-0678-2","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,18]]}}}